Overview

Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain

Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of three doses of quinagolide administered as an extended-release vaginal ring compared to placebo on reduction of moderate to severe endometriosis-related pain
Phase:
Phase 2
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Quinagolide